Synapse - David Spriggs

Results (325)

Nomogram to predict cycle-one serious drug-related toxicity in phase I oncology trials

Journal Article

Hyman, D. M.; Eaton, A. A.; Gounder, M. M.; Smith, G. L.; Pamer, E. G.; Hensley, M. L.; Spriggs, D. R.; Ivy, P.; Iasonos, A.
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Intravenous aflibercept in patients with platinum-resistant, advanced ovarian cancer: Results of a randomized, double-blind, phase 2, parallel-arm study

Journal Article

Tew, W. P.; Colombo, N.; Ray Coquard, I.; Del Campo, J. M.; Oza, A.; Pereira, D.; Mammoliti, S.; Matei, D.; Scambia, G.; Tonkin, K.; more...
Cancer (2014)

Fulltext@MSK | Save

Bevacizumab (Bev) for treatment of recurrent serous borderline (SB) or low-grade serous (LGS) ovarian cancer: A retrospective review of the Memorial Sloan-Kettering Cancer Center (MSKCC) experience

Meeting Abstract

Grisham, R. N.; Sala, E.; Zhou, Q.; Iasonos, A.; DeLair, D.; Iyer, G.; Hyman, D. M.; Spriggs, D. R.; Aghajanian, C.
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Effect of montanide and Poly-ICLC adjuvant on human self/tumor antigen-specific CD4(+) T cells in phase I overlapping long peptide vaccine trial

Journal Article

Tsuji, T.; Sabbatini, P.; Jungbluth, A. A.; Ritter, E.; Pan, L.; Ritter, G.; Ferran, L.; Spriggs, D.; Salazar, A. M.; Gnjatic, S.
Cancer Immunology Research (2013)

Fulltext@MSK | Save

Overexpression of the carboxyl-terminus of MUC16 can accelerate the occurrence of phenotypes in p53 heterozygous mouse model

Meeting Abstract

Tian, H.; Zhou, Q.; Iasonos, A.; Spriggs, D.
Cancer Research (2013)

Fulltext@MSK | Save

Reply to M.L. Friedlander et al

Journal Article

Spriggs, D. R.
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

BRAF Mutation is associated with early stage disease and improved outcome in patients with low-grade serous ovarian cancer

Journal Article

Grisham, R. N.; Iyer, G.; Garg, K.; DeLair, D.; Hyman, D. M.; Zhou, Q.; Iasonos, A.; Berger, M. F.; Dao, F.; Spriggs, D. R.; more...
Cancer (2013)

Fulltext@MSK | Save

BRCA1 immunohistochemistry in high-grade serous ovarian cancers (HGS-OC) characterized for BRCA1 germ-line mutations

Meeting Abstract

Hyman, D. M.; Garg, K.; Grisham, R. N.; Bhatia, J.; Arnold, A. G.; Aghajanian, C.; Kauff, N. D.; Levine, D. A.; Soslow, R. A.; Spriggs, D. R.
Journal of Clinical Oncology (2012)

Fulltext@MSK | Save

Effect of modulation of the hostile tumor microenvironment through adoptive transfer of IL-12 expressing MUC-16 targeted T cells on ovarian tumors in vivo